{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T02:52:48Z","timestamp":1787453568558,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Surgery is the common treatment for early lung cancer with multiple pulmonary nodules, but it is often accompanied by the problem of significant malignancy of other nodules in non-therapeutic areas. In this study, we found that a combined treatment of local radiofrequency ablation (RFA) and melatonin (MLT) greatly improved clinical outcomes for early lung cancer patients with multiple pulmonary nodules by minimizing lung function injury and reducing the probability of malignant transformation or enlargement of nodules in non-ablated areas. Mechanically, as demonstrated in an associated mouse lung tumor model, RFA not only effectively remove treated tumors but also stimulate antitumor immunity, which could inhibit tumor growth in non-ablated areas. MLT enhanced RFA-stimulated NK activity and exerted synergistic antitumor effects with RFA. Transcriptomics and proteomics analyses of residual tumor tissues revealed enhanced oxidative phosphorylation and reduced acidification as well as hypoxia in the tumor microenvironment, which suggests reprogrammed tumor metabolism after combined treatment with RFA and MLT. Analysis of residual tumor further revealed the depressed activity of MAPK, NF-kappa B, Wnt, and Hedgehog pathways and upregulated P53 pathway in tumors, which was in line with the inhibited tumor growth. Combined RFA and MLT treatment also reversed the Warburg effect and decreased tumor malignancy. These findings thus demonstrated that combined treatment of RFA and MLT effectively inhibited the malignancy of non-ablated nodules and provided an innovative non-invasive strategy for treating early lung tumors with multiple pulmonary nodules. Trial registration:\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\">www.chictr.org.cn<\/jats:ext-link>\n                    , identifier ChiCTR2100042695,\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/showproj.aspx?proj=120931\">http:\/\/www.chictr.org.cn\/showproj.aspx?proj=120931<\/jats:ext-link>\n                    .\n                  <\/jats:p>","DOI":"10.1038\/s41392-021-00745-7","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T09:04:06Z","timestamp":1630487046000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Melatonin enhances radiofrequency-induced NK antitumor immunity, causing cancer metabolism reprogramming and inhibition of multiple pulmonary tumor development"],"prefix":"10.1038","volume":"6","author":[{"given":"Ming","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjie","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russel J.","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiansheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liduo","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baigenzhin","family":"Abay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,1]]},"reference":[{"key":"745_CR1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/cac2.12099","volume":"40","author":"X Liu","year":"2020","unstructured":"Liu, X. et al. The mortality of lung cancer attributable to smoking among adults in China and the United States during 1990-2017. Cancer Commun. 40, 611\u2013619 (2020).","journal-title":"Cancer Commun."},{"key":"745_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.canlet.2019.10.009","volume":"468","author":"D Yang","year":"2020","unstructured":"Yang, D., Liu, Y., Bai, C., Wang, X. & Powell, C. A. Epidemiology of lung cancer and lung cancer screening programs in China and the United States. Cancer Lett. 468, 82\u201387 (2020).","journal-title":"Cancer Lett."},{"key":"745_CR3","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/S1470-2045(14)70389-4","volume":"15","author":"N Horeweg","year":"2014","unstructured":"Horeweg, N. et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol. 15, 1332\u20131341 (2014).","journal-title":"Lancet Oncol."},{"key":"745_CR4","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1093\/jnci\/djz041","volume":"111","author":"HA Robbins","year":"2019","unstructured":"Robbins, H. A., Berg, C. D., Cheung, L. C., Chaturvedi, A. K. & Katki, H. A. Identification of candidates for longer lung cancer screening intervals following a negative low-dose computed tomography result. J. Natl Cancer Inst. 111, 996\u2013999 (2019).","journal-title":"J. Natl Cancer Inst."},{"key":"745_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","volume":"389","author":"FR Hirsch","year":"2017","unstructured":"Hirsch, F. R. et al. Lung cancer: current therapies and new targeted treatments. Lancet 389, 299\u2013311 (2017).","journal-title":"Lancet"},{"key":"745_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2147\/OTT.S136579","volume":"11","author":"L-Y Wang","year":"2018","unstructured":"Wang, L.-Y., Cui, J.-J., Guo, A.-X. & Yin, J.-Y. Clinical efficacy and safety of afatinib in the treatment of non-small-cell lung cancer in Chinese patients. Onco. Targets Ther. 11, 529\u2013538 (2018).","journal-title":"Onco. Targets Ther."},{"key":"745_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/srep23252","volume":"6","author":"Z Zhang","year":"2016","unstructured":"Zhang, Z. et al. Surgical outcomes of synchronous multiple primary non-Small cell lung cancers. Sci. Rep. 6, 23252 (2016).","journal-title":"Sci. Rep."},{"key":"745_CR8","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1245\/s10434-019-08109-w","volume":"27","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Imaging features suggestive of multiple primary lung adenocarcinomas. Ann. Surg. Oncol. 27, 2061\u20132070 (2020).","journal-title":"Ann. Surg. Oncol."},{"key":"745_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-020-01361-1","volume":"37","author":"SG Picchi","year":"2020","unstructured":"Picchi, S. G. et al. RFA of primary and metastatic lung tumors: long-term results. Med. Oncol. 37, 35 (2020).","journal-title":"Med. Oncol."},{"key":"745_CR10","doi-asserted-by":"publisher","first-page":"e001038","DOI":"10.1136\/jitc-2020-001038","volume":"8","author":"X Qi","year":"2020","unstructured":"Qi, X. et al. Synergizing sunitinib and radiofrequency ablation to treat hepatocellular cancer by triggering the antitumor immune response. J. Immunother. Cancer 8, e001038 (2020).","journal-title":"J. Immunother. Cancer"},{"key":"745_CR11","doi-asserted-by":"publisher","unstructured":"Kroeze, S. G. C. et al. Stereotactic radiotherapy combined with immune- or targeted therapy for metastatic renal cell carcinoma. BJU Int. https:\/\/doi.org\/10.1111\/bju.15284 (2020).","DOI":"10.1111\/bju.15284"},{"key":"745_CR12","doi-asserted-by":"publisher","first-page":"e199702","DOI":"10.1001\/jamanetworkopen.2019.9702","volume":"2","author":"J Uhlig","year":"2019","unstructured":"Uhlig, J. et al. Comparison of survival rates after a combination of local treatment and systemic therapy vs systemic therapy alone for treatment of stage IV non-small cell lung cancer. JAMA Netw. Open 2, e199702 (2019).","journal-title":"JAMA Netw. Open"},{"key":"745_CR13","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1158\/2326-6066.CIR-19-0744","volume":"8","author":"DW Chen","year":"2020","unstructured":"Chen, D. W. et al. SHP-2 and PD-L1 inhibition combined with radiotherapy enhances systemic antitumor effects in an anti-PD-1-resistant model of non-small-cell lung cancer. Cancer Immunol. Res. 8, 883\u2013894 (2020).","journal-title":"Cancer Immunol. Res."},{"key":"745_CR14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41586-020-2027-0","volume":"579","author":"RM Stein","year":"2020","unstructured":"Stein, R. M. et al. Virtual discovery of melatonin receptor ligands to modulate circadian rhythms. Nature 579, 609\u2013614 (2020).","journal-title":"Nature"},{"key":"745_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-079X.2012.01014.x","volume":"54","author":"JL Mauriz","year":"2013","unstructured":"Mauriz, J. L., Collado, P. S., Veneroso, C., Reiter, R. J. & Gonz\u00e1lez-Gallego, J. A review of the molecular aspects of melatonin\u2019s anti-inflammatory actions: recent insights and new perspectives. J. Pineal Res. 54, 1\u201314 (2013).","journal-title":"J. Pineal Res."},{"key":"745_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/jpi.12267","volume":"59","author":"LC Manchester","year":"2015","unstructured":"Manchester, L. C. et al. Melatonin: an ancient molecule that makes oxygen metabolically tolerable. J. Pineal Res. 59, 403\u2013419 (2015).","journal-title":"J. Pineal Res."},{"key":"745_CR17","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1002\/med.21582","volume":"39","author":"E Gil-Mart\u00edn","year":"2019","unstructured":"Gil-Mart\u00edn, E., Egea, J., Reiter, R. J. & Romero, A. The emergence of melatonin in oncology: focus on colorectal cancer. Med. Res. Rev. 39, 2239\u20132285 (2019).","journal-title":"Med. Res. Rev."},{"key":"745_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.lfs.2018.11.055","volume":"217","author":"W-x Zhang","year":"2019","unstructured":"Zhang, W.-x, He, B.-m, Wu, Y., Qiao, J.-f & Peng, Z.-y Melatonin protects against sepsis-induced cardiac dysfunction by regulating apoptosis and autophagy via activation of SIRT1 in mice. Life Sci. 217, 8\u201315 (2019).","journal-title":"Life Sci."},{"key":"745_CR19","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3390\/ijms18040843","volume":"18","author":"RJ Reiter","year":"2017","unstructured":"Reiter, R. J. et al. Melatonin, a full service anti-cancer agent: inhibition of initiation, progression and metastasis. Int. J. Mol. Sci. 18, 843 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"745_CR20","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1007\/s00018-019-03438-1","volume":"77","author":"RJ Reiter","year":"2020","unstructured":"Reiter, R. J., Sharma, R., Ma, Q., Rorsales\u2011Corral, S. & Chuffa, L. G. Melatonin inhibits Warburg\u2011dependent cancer by redirecting glucose oxidation to the mitochondria: a mechanistic hypothesis. Cell. Mol. Life Sci. 77, 2527\u20132542 (2020).","journal-title":"Cell. Mol. Life Sci."},{"key":"745_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/1061186X.2018.1479756","volume":"27","author":"A Barzegar Behrooz","year":"2019","unstructured":"Barzegar Behrooz, A., Syahir, A. & Ahmad, S. CD133: beyond a cancer stem cell biomarker. J. Drug Target. 27, 257\u2013269 (2019).","journal-title":"J. Drug Target."},{"key":"745_CR22","doi-asserted-by":"publisher","first-page":"117147","DOI":"10.1016\/j.lfs.2019.117147","volume":"241","author":"D Reddy","year":"2020","unstructured":"Reddy, D., Kumavath, R., Tan, T. Z., Ampasala, D. R. & Kumar, A. P. Peruvoside targets apoptosis and autophagy through MAPK Wnt\/\u03b2-catenin and PI3K\/AKT\/mTOR signaling pathways in human cancers. Life Sci. 241, 117147 (2020).","journal-title":"Life Sci."},{"key":"745_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang, L. et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature 520, 57\u201362 (2015).","journal-title":"Nature"},{"key":"745_CR24","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1158\/0008-5472.CAN-19-3578","volume":"80","author":"F-ID Dimitrakopoulos","year":"2020","unstructured":"Dimitrakopoulos, F.-I. D., Kottorou, A. E., Kalofonou, M. & Kalofonos, H. P. The fire within: NF-\u03baB involvement in non-small cell lung cancer. Cancer Res. 80, 4025 (2020).","journal-title":"Cancer Res."},{"key":"745_CR25","doi-asserted-by":"publisher","first-page":"e1501292","DOI":"10.1126\/sciadv.1501292","volume":"2","author":"D Friedmann-Morvinski","year":"2016","unstructured":"Friedmann-Morvinski, D. et al. Targeting NF-\u03baB in glioblastoma: a therapeutic approach. Sci. Adv. 2, e1501292 (2016).","journal-title":"Sci. Adv."},{"key":"745_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09898-0","volume":"10","author":"T Zhan","year":"2019","unstructured":"Zhan, T. et al. MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer. Nat. Commun. 10, 2197 (2019).","journal-title":"Nat. Commun."},{"key":"745_CR27","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.3390\/cancers12092402","volume":"12","author":"D Shin","year":"2020","unstructured":"Shin, D. et al. Midkine is a potential therapeutic target of tumorigenesis, angiogenesis, and metastasis in non-small cell lung cancer. Cancers 12, 2402 (2020).","journal-title":"Cancers"},{"key":"745_CR28","doi-asserted-by":"publisher","first-page":"5544","DOI":"10.1038\/onc.2017.173","volume":"36","author":"A Szczepny","year":"2017","unstructured":"Szczepny, A. et al. The role of canonical and non-canonical Hedgehog signaling in tumor progression in a mouse model of small cell lung cancer. Oncogene 36, 5544\u20135550 (2017).","journal-title":"Oncogene"},{"key":"745_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-03021-3","volume":"7","author":"P Wang","year":"2017","unstructured":"Wang, P. et al. Expression and transcriptional regulation of human ATP6V1A gene in gastric cancers. Sci. Rep. 7, 3015 (2017).","journal-title":"Sci. Rep."},{"key":"745_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.lungcan.2016.06.003","volume":"107","author":"AI Robles","year":"2017","unstructured":"Robles, A. I. & Harris, C. C. Integration of multiple \u201cOMIC\u201d biomarkers: a precision medicine strategy for lung cancer. Lung Cancer 107, 50\u201358 (2017).","journal-title":"Lung Cancer"},{"key":"745_CR31","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","volume":"16","author":"JY Chang","year":"2015","unstructured":"Chang, J. Y. et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol. 16, 630\u2013637 (2015).","journal-title":"Lancet Oncol."},{"key":"745_CR32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.21037\/tlcr.2018.01.16","volume":"7","author":"AF Farago","year":"2018","unstructured":"Farago, A. F. & Keane, F. K. Current standards for clinical management of small cell lung cancer. Transl. Lung Cancer Res. 7, 69\u201379 (2018).","journal-title":"Transl. Lung Cancer Res."},{"key":"745_CR33","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jtcvs.2011.03.035","volume":"142","author":"T Fabian","year":"2011","unstructured":"Fabian, T., Bryant, A. S., Mouhlas, A. L., Federico, J. A. & Cerfolio, R. J. Survival after resection of synchronous non\u2013small cell lung cancer. J. Thorac. Cardiovasc. Surg. 142, 547\u2013553 (2011).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"745_CR34","doi-asserted-by":"publisher","first-page":"764","DOI":"10.3390\/ijms22020764","volume":"22","author":"RJ Reiter","year":"2021","unstructured":"Reiter, R. J., Sharma, R. & Rosales-Corral, S. Anti-warburg effect of melatonin: a proposed mechanism to explain its inhibition of multiple diseases. Int. J. Mol. Sci. 22, 764 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"745_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13019-018-0773-y","volume":"13","author":"J Palussiere","year":"2018","unstructured":"Palussiere, J. et al. Radiofrequency ablation of stage IA non-small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial. J. Cardiothorac. Surg. 13, 91 (2018).","journal-title":"J. Cardiothorac. Surg."},{"key":"745_CR36","doi-asserted-by":"publisher","first-page":"eaba8564","DOI":"10.1126\/sciadv.aba8564","volume":"6","author":"KM Au","year":"2020","unstructured":"Au, K. M., Park, S. I. & Wang, A. Z. Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy. Sci. Adv. 6, eaba8564 (2020).","journal-title":"Sci. Adv."},{"key":"745_CR37","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41577-018-0061-z","volume":"18","author":"L Chiossone","year":"2018","unstructured":"Chiossone, L., Dumas, P.-Y., Vienne, M. & Vivier, E. Natural killer cells and other innate lymphoid cells in cancer. Nat. Rev. Immunol. 18, 671\u2013688 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"745_CR38","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3389\/fimmu.2017.01124","volume":"8","author":"S Paul","year":"2017","unstructured":"Paul, S. & Lal, G. The molecular mechanism of natural killer cells function and its importance in cancer immunotherapy. Front. Immunol. 8, 1124 (2017).","journal-title":"Front. Immunol."},{"key":"745_CR39","doi-asserted-by":"publisher","first-page":"8638","DOI":"10.3390\/ijms14048638","volume":"14","author":"A Carrillo-Vico","year":"2013","unstructured":"Carrillo-Vico, A., Lardone, P. J., Alvarez-Sanchez, N., Rodriguez-Rodriguez, A. & Guerrero, J. M. Melatonin: buffering the immune system. Int. J. Mol. Sci. 14, 8638\u20138683 (2013).","journal-title":"Int. J. Mol. Sci."},{"key":"745_CR40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fimmu.2017.00025","volume":"8","author":"NW Zwirner","year":"2017","unstructured":"Zwirner, N. W. & Ziblat, A. Regulation of NK cell activation and effector functions by the IL-12 family of cytokines: the case of IL-27. Front. Immunol. 8, 25 (2017).","journal-title":"Front. Immunol."},{"key":"745_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxlet.2019.04.033","volume":"312","author":"W Zhu","year":"2019","unstructured":"Zhu, W. et al. Integration of transcriptomics, proteomics and metabolomics data to reveal the biological mechanisms of abrin injury in human lung epithelial cells. Toxicol. Lett. 312, 1\u201310 (2019).","journal-title":"Toxicol. Lett."},{"key":"745_CR42","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1083\/jcb.201702058","volume":"216","author":"PM Quiros","year":"2017","unstructured":"Quiros, P. M. et al. Multi-omics analysis identifies ATF4 as a key regulator of the mitochondrial stress response in mammals. J. Cell. Biol. 216, 2027\u20132045 (2017).","journal-title":"J. Cell. Biol."},{"key":"745_CR43","doi-asserted-by":"publisher","first-page":"e1600200","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis, R. J. & Chandel, N. S. Fundamentals of cancer metabolism. Sci. Adv. 2, e1600200 (2016).","journal-title":"Sci. Adv."},{"key":"745_CR44","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/s41590-019-0511-1","volume":"20","author":"X Zheng","year":"2019","unstructured":"Zheng, X. et al. Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance. Nat. Immunol. 20, 1656\u20131667 (2019).","journal-title":"Nat. Immunol."},{"key":"745_CR45","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3390\/genes11050563","volume":"11","author":"P Jadiya","year":"2020","unstructured":"Jadiya, P. & Tomar, D. Mitochondrial protein quality control mechanisms. Genes 11, 563 (2020).","journal-title":"Genes"},{"key":"745_CR46","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41586-019-0993-x","volume":"567","author":"Y Shi","year":"2019","unstructured":"Shi, Y. et al. Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma. Nature 567, 341\u2013346 (2019).","journal-title":"Nature"},{"key":"745_CR47","doi-asserted-by":"publisher","first-page":"e38659","DOI":"10.1371\/journal.pone.0038659","volume":"7","author":"X Liu","year":"2012","unstructured":"Liu, X. et al. An artificial miRNA against HPSE suppresses melanoma invasion properties, correlating with a down-regulation of chemokines and MAPK phosphorylation. PLoS ONE 7, e38659 (2012).","journal-title":"PLoS ONE"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-021-00745-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-021-00745-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-021-00745-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T09:40:44Z","timestamp":1669801244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-021-00745-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["745"],"URL":"https:\/\/doi.org\/10.1038\/s41392-021-00745-7","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,1]]},"assertion":[{"value":"29 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"330"}}